Evidence map›Paper›PMID 41497893›Full record

ArticleJPRAS open2025

Surgeons, physiatrists and neurologists speaking "EDX and nerve surgery": A paradigm shift for nerve injured patients.

Deng Pan, Aneri U Patel, J Megan Patterson, Anna Rose Johnson, Travis Gordon, Susan E Mackinnon

Registry-linked trialAbstract read
In one paragraph

Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07605585 (Sensory Neurography and S2PD), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07605585 naactive not recruitingnot on this map

Sensory Neurography and S2PD: A Test-Retest Study in Ten Healthy Individuals to Assess Method Reliability

TypeinterventionalSponsorKarolinska InstitutetRan2025 to 2026Enrolled10ConditionsReliability of Sensory Neurography and S2PDArmsS2PD, Sensory neurography
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Deng PanDivision of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, USA.
Aneri U PatelDivision of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, USA.
J Megan PattersonDepartment of Orthopedic Surgery, University of North Carolina, Chapel Hill, 102 Mason Farm Road, NC, USA.
Anna Rose JohnsonDivision of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, USA.
Travis GordonDivision of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, USA.
Susan E MackinnonDivision of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgeons' ability to interpret electrodiagnostic (EDX) studies has greatly enhanced patient selection and outcome for nerve surgeries as it has informed our understanding of the classification of nerve injury. EDX measures axons present, lost, or demyelinated. It does not measure an area where axons experience chronic ischemia, making a Sunderland Zero nerve injury a clinical diagnosis that should be suspected when patients have normal EDX, decreased recruitment on electromyography (EMG), and no atrophy. Only observation of recovery in the earliest postoperative period would confirm a Sunderland Zero. In this article, we present an expanded classification of nerve injury, highlighting Sunderland Zero or ischemic neurapraxia, and provide a historical and pathophysiological overview of how it came to be recognized. We also offer a user-friendly classification and an equation we call the Nerve Injury Calculator (NIC) that calculates the percent axonal loss, demyelinating loss, and ischemic axons to predict timing and quality of recovery. The clinical utility of the NIC is exemplified with three cases. With the development and introduction of the NIC, there is a paradigm shift amongst surgeons, physiatrists, and neurologists that allows us all to speak the same language of EDX and nerve surgery, enabling improved patient education, prediction of prognosis and timing of recovery, and efficient follow up with respect to patients' postoperative period.

Indexed as

EDX studiesnerve injury classificationnerve recoverynerve surgerySunderland Zero

Identifiers

PMID41497893
PMCPMC12766253

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.